European Neurology · 2017 · 29 citations · 8 references
Muscle FunctionImmunologyPathologyAnti-m2 AntibodyAnti-mitochondrial AntibodiesMitochondrial MyopathyKinesiologyMuscle InjurySkeletal MuscleAutoantibodiesAffected MusclesRheumatologyMuscle PathologyAllergyAutoimmune DiseaseDiagnostic ConfirmationSclerodermaAutoantibody ProductionMedicineNeuromusculoskeletal Disorder
Recent studies have revealed the clinical, histological, and pathophysiological characteristics in a group of inflammatory myopathies with selected autoantibodies. We retrospectively compared the clinical manifestations and histological features between 8 anti-mitochondrial (anti-M2) antibody-positive and 33 antibody-negative patients. Patients with anti-M2 antibodies have been previously reported to have delayed diagnostic confirmation and frequent cardiopulmonary complications in comparison to those without the antibodies. In our study, clinical characteristics in patients with the antibodies were as follows: lesser degree of limb muscle weakness and atrophy as well as lymphocytic infiltration in muscle biopsy specimens, and frequent paravertebral muscle atrophy. Anti-M2 antibody appeared to be a biomarker related to not only cardiopulmonary complications, but also characteristic -distributions of affected muscles.
8
Roberto M. Lang, Luigi P. Badano, Victor Mor‐Avi et al. · Journal of the American Society of Echocardiography · 2015 · 17.5K citations · Full text
Health Sciences, Medical Imaging, Cardiovascular Disease +11
Keith D. Lindor, Eric M. Gershwin, Raoul Poupon et al. · Hepatology · 2009 · 1.1K citations
Inflammatory myopathies associated with anti-mitochondrial antibodies
Meiko Hashimoto Maeda, Shoji Tsuji, Jun Shimizu · Brain · 2012 · 133 citations · Full text